ElevateBio says its emerging technology laboratory enables the firm to stay on the cutting-edge of solutions.   Neither a contract development manufacturing organization (CDMO) nor an end-user, cell and gene therapy (CGT) firm ElevateBio, sat down with BioProcess Insider to discuss the importance of technology in the industry and what it is doing to keep up with demand. “Instead of staying current with technology on the cutting edge, whether it’s attending conferences or even working with new device companies […]…

CDMO ten23 has expanded manufacturing capacity of sterile drug products at its Visp, Switzerland facility and will add quality control services in 2024. The Swiss contract development and manufacturing organization (CDMO) ten23 Health confirmed that, after a successful GMP inspection by Swissmedic, its new storage areas in the VIVA facility in Visp, Switzerland are operational. The output of its sterile manufacturing area will gradually increase by 50%. “We are thrilled to offer our customers additional sterile manufacturing capacity for sophisticated…